Marico Q1 FY27: Revenue up 23% YoY to Rs 3,957 cr, PAT up 27% to Rs 652 cr

Revenue Growth 20pctPat Growth 25pctResults RestatedResults View source PDF Explain this filing

MARICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹875.00

prior close

₹878.60

announcement price

After-mkt

timing

Nifty Midcap 150market+0.2%-2.9% vs market

Edible Oil peers, median of 24sector+0.2%-2.8% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Midcap 150 and 2.8 pts less than its Edible Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.0

10m

-3.2

15m

-2.8

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.6+0.2-2.9+0.2-2.8

Next day

-1.7-0.2-1.6+0.0-1.7

-1.7+0.1-1.8-0.1-1.6

-1.3+0.5-1.8+0.6-2.0

-2.3+0.5-2.8+0.8-3.1

-2.9+0.7-3.7+1.7-4.6

-1.1+0.3-1.4+1.3-2.4

15d

-5.1+0.8-5.9-0.3-4.8

-7.9-1.2-6.7-0.8-7.1

-9.7-6.8-2.9-4.3-5.4

—————

UpDownMarket · Nifty Midcap 150Sector · Edible Oil peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Marico Q1 FY27 consolidated revenue grew 22.9% YoY to Rs 3,957 cr from Rs 3,221 cr. Net profit jumped 27.1% to Rs 652 cr from Rs 513 cr. EPS rose to Rs 4.86 vs Rs 3.90. Board approved on Aug 4 with clean limited review by B S R and Co. LLP. Figures restated for Just Herbs and Beardo integration and ad expense reclassification. New Vietnam unit Skinetiq acquired in April 2026.

Likely market impact

Strong double-digit growth in revenue and profit signals robust demand and margin health. Restated figures and new acquisitions lift scale. Positive for shareholders.